IMRIS

IMRIS and University of Michigan Health Announce First ProcedurePerformed Using the IMRIS InVision™ Operating Suite

Curt Schulz — Thu, 19 Mar 2026 13:00:00 +0000

Chaska, MN (March 19, 2026) – IMRIS, the global leader in intraoperative magnetic resonance imaging (iMRI), and University of Michigan Health announce the successful completion of the first surgical procedure performed in the new IMRIS InVision Operating Suite.

The inaugural procedure marks a significant milestone in the medical center’s ongoing commitment to advancing patient care through cutting-edge surgical technology. The InVision Operating Suite integrates advanced intraoperative imaging directly into the operating room, enabling surgeons to access high-quality imaging without moving the patient and to make real-time, data-driven decisions during complex procedures.

The first case performed in the InVision Operating Suite was a Laser Interstitial Thermal Therapy (LITT) procedure. LITT is a minimally invasive technique commonly used to treat intracranial lesions, including tumors and epileptogenic foci, where precise thermal control and immediate imaging feedback are critical. The InVision Operating Suite enables surgeons to perform LITT procedures with seamless access to high-field intraoperative MRI, allowing for real-time visualization of ablation progress and immediate confirmation of treatment margins without patient transport.

“With intraoperative MRI, our neurosurgical teams have access to real-time brain imaging without having to move the patient to a different location, allowing them to be precise and complete in removing disease-causing lesions of the brain. In addition, the MRI allows us to not only visualize the brain structures but also the temperature of those structures. This functionality can be leveraged to apply minimally invasive laser-based therapy in the MROR.” – Aditya S. Pandey, M.D., Chair, Department of Neurosurgery, University of Michigan Health

The IMRIS InVision Operating Suite is designed to support a wide range of surgical specialties, including neurosurgery, upper cervical spine, and other complex procedures. By seamlessly integrating imaging, surgical space, and digital workflows, the suite helps reduce uncertainty, streamline procedures, and potentially minimize the need for follow-up interventions.

“We are proud to collaborate with University of Michigan Health as they bring the IMRIS InVision Operating Suite into clinical use,” said Shalabh Chandra, CEO of IMRIS. “This first procedure reflects the shared vision between IMRIS and leading academic medical centers to push the boundaries of image-guided surgery.”

University of Michigan Health joins a growing number of leading healthcare institutions worldwide adopting IMRIS technology to support advanced surgical care, research, and education. The InVision Suite is expected to play a key role in training future surgeons while supporting innovation in complex surgical techniques.

About IMRIS

IMRIS is a global leader in advanced image-guided surgical solutions designed to improve surgical precision and patient outcomes. With installations at leading hospitals and academic medical centers worldwide, IMRIS technology integrates imaging, operating rooms, and digital workflows to support complex procedures across multiple specialties. For more information, visit www.imris.com

About Michigan Medicine and University of Michigan Health

At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our 12 hospitals and hundreds of clinics statewide, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes U-M Medical School and University of Michigan Health, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center, the D. Dan and Betty Kahn Health Care Pavilion, Kellogg Eye Center, University of Michigan Health-West, University of Michigan Health-Sparrow and the Rogel Cancer Center. The U-M Medical School is one of the nation’s biomedical research powerhouses, with total research awards of more than $800 million. More information is available at www.michiganmedicine.org

IMRIS and SpinTech MRI Announce Strategic Collaboration to Transform Neurosurgery with Enhanced MR Imaging

Curt Schulz — Tue, 13 Jan 2026 14:00:00 +0000

Chaska, MN (January 13, 2026) – IMRIS, the global leader in intraoperative magnetic resonance imaging (iMRI)surgical theatres, and SpinTech MRI, an innovative medical imaging software company, are pleased to announce a strategic collaboration aimed at integrating SpinTech’s advanced neuro-imaging software solutions into the IMRIS InVision Surgical Theatre platform. This partnership is set to dramatically improve surgical precision and efficiency for neurosurgical procedures.

The integration combines the unique IMRIS moving-magnet iMRI system, which brings high-field diagnostic quality MRI to the patient on the operating table without moving them, with SpinTech’s STAGE software platform, which uses artificial intelligence to streamline MRI acquisition and post-processing.

Enhancing surgical decision-making and workflow neurosurgery requires the highest level of precision, and the ability to perform real-time intraoperative imaging is critical for confirming tumor resection or guiding device placement. The challenge in the past has been the time required for image acquisition and processing during surgery.

This collaboration addresses that challenge head-on:

– Accelerated Workflow: SpinTech’s STAGE software has been shown to reduce MRI brain exam times by approximately 30%. By integrating this technology into the IMRIS workflow, neurosurgeons will gain faster access to critical intraoperative images, potentially reducing overall procedure times and improving patient throughput.

– Superior Image Quality: The combined solution aims to deliver enhanced3T-quality resolution and detailed quantitative outputs for confident interpretation, even from 1.5T systems. This provides surgeons with clearer, more detailed anatomical views and “GPS-like guidance” during delicate procedures.

– Optimized Surgical Experience: The IMRIS system allows the patient to remain in a sterile surgical position while the magnet moves to them. The addition of rapid, high-quality imaging from SpinTech’s software further optimizes this unique environment, ensuring maximum patient safety and surgical precision.

“IMRIS is excited to collaborate with SpinTech MRI to allow all of our customers to take advantage of state-of-the-art diagnostic and surgical capabilities that the STAGE product will bring into our InVision Surgical Theatres,” says IMRIS CEO Shalabh Chandra. “Our collaboration with SpinTech MRI is an exciting step in our commitment to innovation, leveraging STAGE to provide faster, more detailed imaging feedback to surgical teams without compromising on quality or workflow.”

“Our mission at SpinTech MRI is to push the boundaries of what’s possible with MRI while delivering practical, high-impact solutions for Neurosurgeons,” said Karen Holzberger, CEO of SpinTech MRI. “Partnering with IMRIS allows us to bring the benefits of our accelerated, quantitative imaging software into the high-stakes intraoperative setting, where efficiency and accuracy are paramount.”

The integrated solution will be available to IMRIS customers in the United States, enhancing the capabilities of the InVision Surgical Theatre in leading medical institutions for complex neurosurgical cases, including tumor resections and epilepsy treatments.

About IMRIS

IMRIS Imaging, Inc., is the global leader in providing image guided therapy solutions through its InVision Surgical Theatre, a revolutionary, multifunctional surgical environment that incorporates diagnostic quality high-field MRI into multi-purpose surgical suites. Its unique ceiling-mounted, moving-magnet system provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment.

About SpinTech MRI

SpinTech MRI, based in Bingham Farms, Michigan, is a software medical device company at the frontier of brain imaging and MRI technology. The company develops and provides a comprehensive software platform for improving the diagnosis and treatment of neurological conditions, significantly reducing exam times and enhancing image quality through its innovative STAGE technology.

IMRIS Imaging, Inc. Announces Shalabh Chandra as Chief Executive Officer

Curt Schulz — Fri, 26 Sep 2025 19:10:26 +0000

Chaska, MN (September 26, 2025) – IMRIS Imaging, Inc., the global leader in intraoperative imaging, is pleased to announce that its Board of Directors has appointed Shalabh Chandra as Chief Executive Officer effective September 22, 2025.

Shalabh is a customer-focused operating leader with broad business acumen and a proven track record of driving profitable growth, leading strategic market transformations, and building global partnerships. He has successfully grown and revitalized businesses at various stages, turning them into regional and global successes. Shalabh joins IMRIS with senior leadership experience as well as serving as a Global Business Leader for several high growth companies. “We are pleased to welcome Shalabh to IMRIS as we continue to expand our product portfolio,” said Dr. Gregory Sorensen, Executive Chairman.

IMRIS has recently launched its newest operating suite, the InVision 3T Recharge featuring the Siemens Skyra Fit upgrade, a ceiling-mounted intraoperative MRI system specifically designed for diagnostic and intraoperative imaging. The 3T Recharge provides an upgrade path for IMRIS Operating Suites currently utilizing Siemens Verio magnets.

“The 3T Recharge is a recent example of IMRIS continuing to drive innovation. The company is experiencing remarkable growth through the continued advancement of its InVision moving magnet systems. I’m thrilled to join a company so deeply dedicated to enhancing surgical outcomes for patients,” said Shalabh Chandra.

About IMRIS Imaging, Inc.

As a leader in image guidance solutions, IMRIS, provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Operating Suite enables intraoperative imaging directly within operating rooms. The Company also designs and manufactures proprietary head fixation devices, imaging coils and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular and orthopedic markets. It is estimated that over 70,000 patients have benefited from lifesaving or life-extending procedures performed in an IMRIS Operating Suite. Additional information about IMRIS is available at www.imris.com.

IMRIS Imaging, Inc. Contact:

Chelsey Wentz
Marketing Specialist II
cwentz@imris.com

IMRIS Imaging, Inc. Receives FDA Clearance for the InVision™ 3T Recharge Operating Suite

Curt Schulz — Tue, 12 Aug 2025 13:00:00 +0000

Chaska, MN (August 12, 2025) – IMRIS Imaging, Inc., the global leader in intraoperative imaging, announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new InVision 3T Recharge Operating Suite, a ceiling-mounted intraoperative MRI system specifically designed for diagnostic and intraoperative imaging. The InVision 3T Recharge provides an upgrade path for IMRIS Operating Suites currently utilizing Siemens’ MAGNETOM Verio magnets, enabling them with the new advanced capabilities of Siemens’ MAGNETOM Skyra Fit upgrade. The upgrade platform enables IMRIS customers to take advantage of the latest Siemens MRI technology including improved diagnostic imaging quality. Workflows are streamlined through AI powered imaging protocols and with automatic image reconstruction post processing managed as a background activity, enabling increases in productivity while reducing scan times.

“We’re delighted to be able to offer our IMRIS customers currently using the Siemens Verio platform this significant upgrade to their InVision System,” said IMRIS CEO Marc Buntaine. “The InVision 3T Recharge brings the latest state-of-the-art Siemens Skyra Fit Biomatrix technology to an IMRIS Operating Suite, extending the life of the initial investment and enabling IMRIS intraoperative MRI value to be enhanced at these clinical centers.”

IMRIS custom designs innovative intraoperative MRI systems specifically for imaging during neurosurgical procedures. An IMRIS InVision Operating Suite helps deliver timely information to clinicians, providing real-time visualization to assist in decision-making and enhance precision in treatment.

About IMRIS Imaging, Inc.

As a leader in image guidance solutions, IMRIS Imaging, Inc., provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Operating Suite enables intraoperative imaging directly within operating rooms. The Company also designs and manufactures proprietary head fixation devices, imaging coils and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular and orthopedic markets. It is estimated that over 70,000 patients have benefited from lifesaving or life-extending procedures performed in an IMRIS Operating Suite. Additional information about IMRIS is available at www.imris.com.

IMRIS Imaging, Inc. Contact:

Chelsey Wentz, Marketing Specialist

cwentz@imris.com

Grovecourt Capital Partners Announces Acquisition of IMRIS

Curt Schulz — Wed, 19 Feb 2025 17:45:09 +0000

West Palm Beach, FL (February 19, 2025) – Grovecourt Capital Partners (“Grovecourt”), a West Palm Beach, FL based private equity firm, is pleased to announce the acquisition of IMRIS Imaging, Inc. (“IMRIS”), the global leader of intraoperative MRI solutions. Financial terms of the transaction were not disclosed.

Founded in 2005 and headquartered in Chaska, MN, IMRIS is the leading provider of advanced neurosurgery operating theatres. IMRIS designs, manufactures and services its proprietary intraoperative MRI suites utilized by scores of hospitals and cancer centers worldwide. IMRIS provides the only movable MRI that operates on a ceiling mounted rail system, seamlessly gliding between a diagnostic room and operating rooms, bringing the MRI machine directly to the patient. The company’s intraoperative MRI solutions enable patients to remain in a sterile surgical position for intraoperative imaging during neurosurgery and other growing use cases. IMRIS’s technology enhances surgical precision, reduces the need for follow-up procedures, and eliminates post-surgical confirmatory MRI scans.

“IMRIS stands at the forefront of intraoperative medical imaging,” said Matt Bergin, Managing Partner at Grovecourt. “As seasoned investors in the medical imaging space, we are thrilled to partner with Marc Buntaine, Greg Sorensen, and the entire IMRIS team to drive innovation, expand the company’s products and services and enhance patient care.”

Marc Buntaine, CEO of IMRIS, commented, “Our partnership with Grovecourt marks a significant milestone for IMRIS. As the longstanding leader of intraoperative MRI systems for neurosurgery, we are eager to expand the boundaries of intraoperative MRI imaging into emerging applications, such as laser ablation and high intensity focused ultrasound procedures.”

Dr. Gregory Sorensen, IMRIS’s Executive Chairman, expressed his enthusiasm for the partnership, stating, “This partnership with Grovecourt will enable us to enter a new phase of growth and accelerate IMRIS’ mission to improve patient care through innovative intraoperative technologies. We are so excited for this partnership and the opportunities ahead.”

Holland & Knight acted as legal advisor to Grovecourt. Ocean Avenue Capital Partners, Bell Capital Finance – a division of Bell Bank, and Farragut Capital Partners provided financing for the transaction. CMD Global Partners acted as exclusive financial advisor to IMRIS.

About IMRIS

IMRIS designs, manufactures, and services its proprietary intraoperative MRI suites for use in leading hospitals and cancer centers throughout the world. The company’s MRI systems empower neurosurgeons to perform minimally invasive procedures. It is estimated that over 70,000 patients worldwide have benefited from image-guided therapy solutions provided by IMRIS. For more information, visit www.imris.com.

About Grovecourt Capital Partners

Grovecourt Capital Partners is a private equity firm based in West Palm Beach, FL, specializing in investments in founder-led and family-owned businesses in the lower middle market. With an investment focus in the business services and healthcare services sectors, Grovecourt partners with management teams to execute both organic and inorganic growth opportunities, optimize performance, and create long-term value. For more information, visit www.grovecourtcapital.com.

IMRIS, Deerfield Imaging Receives FDA Clearance for the InVision™ 1.5 Surgical Theatre

Curt Schulz — Wed, 21 Feb 2024 19:30:29 +0000

Chaska, MN (February 21, 2024) – IMRIS, Deerfield Imaging, the global leader in intraoperative imaging, announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new InVision 1.5 Surgical Theatre, a ceiling-mounted intraoperative MRI system specifically designed for imaging during surgical procedures in a multi-room operating suite. This newest technology is a 1.5T system that provides high quality imaging for neurosurgical applications.

“We’re excited to receive regulatory clearance for commercialization of our InVision 1.5 Surgical Theatre,” said IMRIS CEO Marc Buntaine. “IMRIS continues to innovate and provide intraoperative imaging solutions that support the clinical needs of hospitals and doctors that treat neurological disorders. This new InVision system further expands and complements the IMRIS product portfolio by offering the latest innovations in 1.5T MRI.”

IMRIS custom designs innovative intraoperative MRI systems specifically for imaging during neurosurgical procedures. An IMRIS InVision Surgical Theatre helps deliver timely information to clinicians, providing real-time visualization to assist in decision-making and enhance precision in treatment.

About IMRIS, Deerfield Imaging

As a leader in image guidance solutions, IMRIS, Deerfield Imaging provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Surgical Theatre enables intraoperative imaging directly within operating rooms. The Company also designs and manufactures proprietary head fixation devices, imaging coils and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular and orthopedic markets. Over 70,000 patients have benefited from lifesaving or life-extending procedures performed in an IMRIS Surgical Theatre in the past 17 years. Additional information about IMRIS, Deerfield Imaging is available at www.imris.com.

IMRIS, Deerfield Imaging Contact:

Alan Weinberg
VP, Marketing and Product Management
aweinberg@imris.com.

IMRIS and Insightec Enter Into a Collaboration to Enable Technology Integration

Curt Schulz — Wed, 14 Feb 2024 17:18:02 +0000

Chaska, MN and Miami, FL (February 14, 2024) – IMRIS, Deerfield Imaging, the global leader in intraoperative MRI and Insightec, the market leader in therapeutic focused ultrasound for neurological disorders have entered into a collaboration agreement that will enable Insightec systems to seamlessly operate within IMRIS InVision Surgical Theatres. The collaboration will result in technology integration enabling hospitals and physicians the ability to expand their treatment capabilities within IMRIS surgical suites using focused ultrasound.

“IMRIS is excited to collaborate with Insightec to bring focused ultrasound capabilities into our InVision Surgical Theatres,” says IMRIS CEO Marc Butaine. “Focused ultrasound can offer significant clinical benefits to patients with neurological disorders, such as essential tremor and Parkinson’s disease, and the IMRIS suite provides an MRI-ready destination within a hospital to help expand access to this treatment.”

“Through our collaboration with IMRIS, we can expand our Exablate Neuro footprint significantly, bringing focused ultrasound treatment closer to patients suffering from the debilitating effects of movement disorders,” adds Maurice R. Ferré M.D., Insightec CEO. “Insightec continues to lead the way in delivering focused ultrasound technologies to hospitals and doctors for innovative treatments in neurosurgery.”

Collaboration efforts will focus on Insightec system validation across the various configurations of IMRIS Surgical Theatres and will also include optimization of signal and electrical interfacing and procedural workflow. The collaboration may provide opportunities for additional technology projects and business development activities between the two organizations.

About IMRIS, Deerfield Imaging

As a leader in image guidance solutions, IMRIS, Deerfield Imaging provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Surgical Theatre enables intraoperative imaging directly within operating rooms. The company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular, and orthopedic markets. It is estimated that over 70,000 patients worldwide have benefited from image-guided therapy solutions integrated into the InVision Surgical Theatre. Additional information about IMRIS, Deerfield Imaging is available at www.imris.com.

About Insightec

Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company’s Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson’s disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo. Additional information about Insightec is available at www.insightec.com.

IMRIS, Deerfield Imaging Contact:
Alan Weinberg
VP, Marketing and Product Management
aweinberg@imris.com

Insightec Contact:
Katherine Juergens
Director of Corporate Communications and Branding
katherinej@insightec.com

Moving Surgery Forward with Real-time Advanced Diagnostic Imaging

Curt Schulz — Wed, 10 Jan 2024 17:43:57 +0000

Introducing IMRIS at MedStar Georgetown University Hospital’s Verstandig Pavilion.

WASHINGTON – Inside the Verstandig Pavilion at MedStar Georgetown University Hospital, the spirit of world-class care in a world-class facility is exemplified by its new cutting-edge Intraoperative MRI System (IMRIS) — a first for the Washington region. With IMRIS, neurosurgeons can ensure the success of brain tumor resections while in the middle of an operation. Knowing that a brain tumor has been completely removed can lead to fewer repeat surgeries, less post-operative imaging, better outcomes, and less stress for patients.

What is IMRIS?

IMRIS uses MRI technology to digitally map a patient’s brain, head, and neck during brain surgery. This advanced imaging technology is fully-integrated into two brand new operating rooms. The twin ORs are adjoined by a central core, housing the large and powerful magnet that drives the system’s imaging capabilities. In an adjacent control room, the magnet can be rotated by 90 degrees each way and moved between operating rooms through a track built into the ceiling directly to the patient.

No other moving-magnet IMRIS system in the region gives clinicians the ability to perform real-time imaging without transferring surgery patients outside the operating room. Imaging while the patient is secured in the OR maximizes patient safety, surgical precision, and assurance for the patient’s family that their loved one is receiving the best possible care.

Read full article.

Black Forest Medical Group and IMRIS Launch Innovative Cranial Stabilization Set for Intraoperative MRI in Neurosurgical Applications

Curt Schulz — Fri, 27 Oct 2023 13:33:00 +0000

Chaska, MN, USA and Freiburg, Germany – IMRIS, Deerfield Imaging and Black Forest Medical Group are excited to announce the market launch of a new cranial stabilization system that enables intraoperative MRI imaging in neurosurgical applications. Both companies have leveraged their expertise in this collaboration, resulting in a state-of-the-art system that offers unparalleled benefits for neurosurgeons and their teams.

The DORO LUCENT® iMRI Set IMRIS is a significant development in the field of intraoperative MRI, a modality that has become increasingly important in today’s neurosurgical operating rooms. IMRIS provides the only iMRI system in the world where the magnet is brought directly to the patient, minimizing impact to the surgical environment and increasing patient safety. With iMRI, patient images can be acquired during a surgical procedure to enable quick and accurate information for immediate treatment while the patient is still in the Surgical Theatre.

The DORO LUCENT® iMRI Set IMRIS is compatibile with all image-guided surgery (IGS) systems from leading companies, providing flexibility and interoperability. In addition to its compatibility, the system’s lightweight, slim, and convenient design ensures ease of management during procedures and offers superior patient positioning. The DORO LUCENT® iMRI Coil Connector IMRIS interface can be adjusted continuously, allowing for precise positioning. The system’s optimized screws enable fast and efficient handling, while the DORO® exclusive Quick-Rail facilitates easy adaptation of surgical accessories to the skull clamp.

Matthias Schuele, Managing Director of Black Forest Medical Group, expressed his pride in the partnership with IMRIS and their joint development, stating: “Our collaboration has significantly enhanced our offering of cranial stabilization systems that support intra-operative MR imaging, fostering our role as the leading developer and manufacturer in intra-operative cranial stabilization solutions. Marc Buntaine, CEO of IMRIS stated, “We are delighted to announce the market launch of this new system in partnership with Black Forest Medical Group. Our collaboration has resulted in a solution that provides exceptional advantages for both neurosurgeons and patients.

The new cranial stabilization system is FDA, MDR compliant and currently available for purchase. Please contact either your local DORO® or IMRIS sales representative for more details.

About Black Forest Medical Group

Evolving from 25 years of experience in neurosurgery and industry advancements, Black Forest Medical Group has achieved a unique competence in neurosurgical medical technology around the globe.

Neurosurgeons worldwide trust in DORO® Cranial Stabilization and Retractor Systems, to perform life-saving surgeries efficiently and safely. The compatibility with OR tables and surgical equipment from different manufacturers offers the decisive advantage.

A large network of medical technology opinion leaders and industry experts drives innovation and supports Black Forest Medical Group in following its vision to create a new world in neurosurgery.

About IMRIS, Deerfield Imaging

As a leader in image guidance solutions, IMRIS, Deerfield Imaging provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Surgical Theatre enables intraoperative imaging directly within operating rooms. The Company also designs and manufactures proprietary head fixation devices, imaging coils and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular and orthopedic markets. It is estimated that over 70,000 patients have benefited from lifesaving or life-extending procedures performed in an IMRIS Surgical Theatre in the past 17 years. Additional information about IMRIS, Deerfield Imaging is available at www.imris.com.

IMRIS, Deerfield Imaging Relocates Its Headquarters to a State-of-Art Facility in Chaska, Minnesota

Curt Schulz — Tue, 17 Oct 2023 18:58:57 +0000

Chaska, MN (October 17, 2023) – IMRIS, Deerfield Imaging, the global leader in intraoperative MRI has relocated its headquarters to a new, modern facility in Chaska, MN. The move supports the ongoing growth of IMRIS and the need for additional space to further the development and commercialization of its intraoperative imaging technologies. The new facility was custom designed for IMRIS and provides advanced research & development laboratories, engineering services, customer support, sales, marketing and administrative functions.

IMRIS CEO Marc Buntaine commented “IMRIS is excited to be in a state-of the-art building that will enhance technology and business development. IMRIS continues to evolve as a leader in intraoperative imaging, and our new facility will enable programs to further innovation, benefiting clinicians and their patients”

The new facility includes a customized buildout that houses multiple IMRIS surgical imaging suite labs. These fully functional multi-room MRI theatres enable technology development, system validation and training resources for new and existing IMRIS technologies.

About IMRIS, Deerfield Imaging

As a leader in image guidance solutions, IMRIS, Deerfield Imaging provides optimized, fully integrated image-guided therapy environments that address the important needs of patients, clinicians, and hospitals by delivering timely MRI and imaging data to clinicians for use during surgical or interventional procedures. The IMRIS Surgical Theatre enables intraoperative imaging directly within operating rooms. The Company also designs and manufactures proprietary head fixation devices, imaging coils and OR tables for use in this unique and multifunctional intraoperative environment. IMRIS products are sold globally to clinical centers in the neurosurgical, spinal, cardiovascular and orthopedic markets. It is estimated that over 70,000 patients worldwide have benefited from image-guided therapy solutions integrated into the IMRIS Surgical Theatre. Additional information about IMRIS, Deerfield Imaging is available at www.imris.com.

IMRIS, Deerfield Imaging Contact:

Alan Weinberg

VP, Marketing and Product Management

aweinberg@imris.com